Picture a busy hospital pharmacy running low on a critical sterile injectable during a nationwide shortage, or an elderly patient struggling with standard hormone therapy because of allergies to common fillers. In moments like these, US compounding pharmacies step in as essential partners, creating customized medications that commercial drugs cannot provide. The latest industry forecast reveals...

Picture a busy hospital pharmacy running low on a critical sterile injectable during a nationwide shortage, or an elderly patient struggling with standard hormone therapy because of allergies to common fillers. In moments like these, US compounding pharmacies step in as essential partners, creating customized medications that commercial drugs cannot provide. The latest industry forecast reveals...

NEWARK, DE — The global vaginal yeast infections treatment market is set for steady expansion, growing from USD 4.4 billion in 2026 to USD 7.7 billion by 2036, registering a CAGR of 5.7%, according to Future Market Insights (FMI). Market growth is primarily fueled by increasing prevalence of infections, rising patient awareness, and expanding access to over-the-counter (OTC) and...